Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 8, 2015, Pages 1826-1834

  Liu, Jing ^a   Lu, Hong ^a   Howatt, Deborah A ^a   Balakrishnan, Anju ^a   Moorleghen, Jessica J ^a   Sorci Thomas, Mary ^b   Cassis, Lisa A ^a   Daugherty, Alan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

angiotensins; aortic aneurysm; hypercholesterolemia; lipoproteins; receptors, LDL

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; EZETIMIBE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; APOB PROTEIN, MOUSE; AZETIDINE DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA RUPTURE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN DIET; ABDOMINAL AORTA; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; COMPLICATION; DEFICIENCY; DISEASE MODEL; FEMALE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SEX DIFFERENCE;

ANGIOTENSIN II; ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; APOLIPOPROTEINS E; AZETIDINES; DIET, WESTERN; DISEASE MODELS, ANIMAL; EZETIMIBE; FEMALE; HYPERCHOLESTEROLEMIA; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; SEX FACTORS;

EID: 84938062520     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305482     Document Type: Article

References (56)

1. Forsdahl SH, Singh K, Solberg S, Jacobsen BK., Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001. Circulation 2009 119 2202 2208. doi: 10.1161/CIRCULATIONAHA.108.817619
2. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, Barone GW, Bandyk D, Moneta GL, Makhoul RG., The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 2000 160 1425 1430
3. Alcorn HG, Wolfson SK Jr, Sutton-Tyrrell K, Kuller LH, O'Leary D., Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996 16 963 970
4. Norrgård O, Angquist KA, Johnson O., Familial aortic aneurysms: serum concentrations of triglyceride, cholesterol, HDL-cholesterol and (VLDL + LDL)-cholesterol. Br J Surg 1985 72 113 116
5. Bradley DT, Hughes AE, Badger SA, A variant in LDLR is associated with abdominal aortic aneurysm. Circ Cardiovasc Genet 2013 6 498 504. doi: 10.1161/CIRCGENETICS.113.000165
6. Simoni G, Gianotti A, Ardia A, Baiardi A, Galleano R, Civalleri D., Screening study of abdominal aortic aneurysm in a general population: lipid parameters. Cardiovasc Surg 1996 4 445 448
7. Singh K, Bønaa KH, Jacobsen BK, Bjørk L, Solberg S., Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: The Tromsø Study. Am J Epidemiol 2001 154 236 244
8. Wanhainen A, Björck M, Boman K, Rutegård J, Bergqvist D., Influence of diagnostic criteria on the prevalence of abdominal aortic aneurysm. J Vasc Surg 2001 34 229 235. doi: 10.1067/mva.2001.115801
9. Louwrens HD, Adamson J, Powell JT, Greenhalgh RM., Risk factors for atherosclerosis in men with stenosing or aneurysmal disease of the abdominal aorta. Int Angiol 1993 12 21 24
10. Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN., The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis 1998 141 133 139
11. Rizzo M, Krayenbühl PA, Pernice V, Frasheri A, Battista Rini G, Berneis K., LDL size and subclasses in patients with abdominal aortic aneurysm. Int J Cardiol 2009 134 406 408. doi: 10.1016/j.ijcard.2007.12.082
12. Van Kuijk JP, Flu WJ, Witteveen OP, Voute M, Bax JJ, Poldermans D., The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms. J Cardiovasc Surg (Torino) 2009 50 599 609
13. de Céniga MV, Blanco-Colio LM, Tuñón J, Egido J, Martín-Ventura JL., Statin use in aortic aneurismal disease to prevent progression and cardiovascular events: review of experimental and clinical data C. Curr Vasc Pharmacol 2013 11 299 304
14. Daugherty A, Cassis LA., Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004 24 429 434. doi: 10.1161/01.ATV.0000118013.72016.ea
15. Daugherty A, Cassis L., Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor-/-mice. Ann N Y Acad Sci 1999 892 108 118
16. Daugherty A, Manning MW, Cassis LA., Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000 105 1605 1612. doi: 10.1172/JCI7818
17. Daugherty A, Manning MW, Cassis LA., Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001 134 865 870. doi: 10.1038/sj.bjp.0704331
18. Liu J, Daugherty A, Lu H., Angiotensin II and abdominal aortic aneurysms: an update. Curr Pharm Design 2015. In press
19. Deng GG, Martin-McNulty B, Sukovich DA, Freay A, Halks-Miller M, Thinnes T, Loskutoff DJ, Carmeliet P, Dole WP, Wang YX., Urokinase-Type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 2003 92 510 517. doi: 10.1161/01.RES.0000061571.49375.E1
20. King VL, Trivedi DB, Gitlin JM, Loftin CD., Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler Thromb Vasc Biol 2006 26 1137 1143. doi: 10.1161/01.ATV.0000216119.79008.ac
21. Tieu BC, Lee C, Sun H, Lejeune W, Recinos A 3rd, Ju X, Spratt H, Guo DC, Milewicz D, Tilton RG, Brasier AR., An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest 2009 119 3637 3651. doi: 10.1172/JCI38308
22. Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S, Huang J, Offenstadt G, Combadière C, Rénia L, Johnson JL, Tharaux PL, Tedgui A, Mallat Z., TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest 2010 120 422 432. doi: 10.1172/JCI38136
23. Uchida HA, Poduri A, Subramanian V, Cassis LA, Daugherty A., Urokinase-Type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2011 31 2845 2852. doi: 10.1161/ATVBAHA.111.234997
24. Torsney E, Pirianov G, Charolidi N, Shoreim A, Gaze D, Petrova S, Laing K, Meisinger T, Xiong W, Baxter BT, Cockerill GW., Elevation of plasma high-density lipoproteins inhibits development of experimental abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2012 32 2678 2686. doi: 10.1161/ATVBAHA.112.00009
25. Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA., Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2009 29 1458 1464. doi: 10.1161/ATVBAHA.109.192658
26. Owens AP 3rd, Passam FH, Antoniak S, Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest 2012 122 558 568. doi: 10.1172/JCI58969
27. Henriques TA, Huang J, D'Souza SS, Daugherty A, Cassis LA., Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice. Endocrinology 2004 145 3866 3872. doi: 10.1210/en.2003-1615
28. Henriques T, Zhang X, Yiannikouris FB, Daugherty A, Cassis LA., Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2008 28 1251 1256. doi: 10.1161/ATVBAHA.107.160382
29. Zhang X, Thatcher SE, Rateri DL, Bruemmer D, Charnigo R, Daugherty A, Cassis LA., Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms. Circ Res 2012 110 e73 e85. doi: 10.1161/CIRCRESAHA.111.253880
30. Rader DJ, Daugherty A., Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008 451 904 913. doi: 10.1038/nature06796
31. Lu H, Daugherty A., Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol 2015 26 152 153. doi: 10.1097/MOL.0000000000000166
32. Rizzo M, Pernice V, Frasheri A, Di Lorenzo G, Rini GB, Spinas GA, Berneis K., Small, dense low-density lipoproteins (LDL) are predictors of cardio-And cerebro-vascular events in subjects with the metabolic syndrome. Clin Endocrinol (Oxf) 2009 70 870 875. doi: 10.1111/j.1365-2265.2008.03407.x
33. Golledge J, van Bockxmeer F, Jamrozik K, McCann M, Norman PE., Association between serum lipoproteins and abdominal aortic aneurysm. Am J Cardiol 2010 105 1480 1484. doi: 10.1016/j.amjcard.2009.12.076
34. Ahnström J, Gottsäter A, Lindblad B, Dahlbäck B., Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysms. Clin Biochem 2010 43 407 410. doi: 10.1016/j.clinbiochem.2009.11.006
35. Major AS, Dove DE, Ishiguro H, Su YR, Brown AM, Liu L, Carter KJ, Linton MF, Fazio S., Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice. Arterioscler Thromb Vasc Biol 2001 21 1790 1795
36. Valenta DT, Bulgrien JJ, Banka CL, Curtiss LK., Overexpression of human ApoAI transgene provides long-Term atheroprotection in LDL receptor-deficient mice. Atherosclerosis 2006 189 255 263. doi: 10.1016/j.atherosclerosis.2005.12.019
37. Su YR, Blakemore JL, Zhang Y, Linton MF, Fazio S., Lentiviral transduction of apoAI into hematopoietic progenitor cells and macrophages: applications to cell therapy of atherosclerosis. Arterioscler Thromb Vasc Biol 2008 28 1439 1446. doi: 10.1161/ATVBAHA.107.160093
38. Zhang SH, Reddick RL, Avdievich E, Surles LK, Jones RG, Reynolds JB, Quarfordt SH, Maeda N., Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J Clin Invest 1997 99 2858 2866. doi: 10.1172/JCI119479
39. Plummer MR, Hasty AH., Atherosclerotic lesion formation and triglyceride storage in obese apolipoprotein AI-deficient mice. J Nutr Biochem 2008 19 664 673. doi: 10.1016/j.jnutbio.2007.08.009
40. Yokota H, Hashimoto Y, Okubo S, Yumoto M, Mashige F, Kawamura M, Kotani K, Usuki Y, Shimada S, Kitamura K, Nakahara K., Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD. Atherosclerosis 2002 162 399 407
41. Ikewaki K, Matsunaga A, Han H, Watanabe H, Endo A, Tohyama J, Kuno M, Mogi J, Sugimoto K, Tada N, Sasaki J, Mochizuki S., A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease. Atherosclerosis 2004 172 39 45
42. Burillo E, Lindholt JS, Molina-Sanchez P, ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression. Thromb Haemost 2015 113. doi: 10.1160/TH14-10-0874
43. Owens AP 3rd, Rateri DL, Howatt DA, Moore KJ, Tobias PS, Curtiss LK, Lu H, Cassis LA, Daugherty A., MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4. Arterioscler Thromb Vasc Biol 2011 31 2813 2819. doi: 10.1161/ATVBAHA.111.238642
44. Takagi H, Manabe H, Kawai N, Goto SN, Umemoto T., Plasma tissue plasminogen activator and abdominal aortic aneurysm presence: a systematic review and meta-Analysis. Ann Vasc Surg 2010 24 686 689. doi: 10.1016/j.avsg.2010.02.005
45. Hobbs SD, Claridge MW, Quick CR, Day NE, Bradbury AW, Wilmink AB., LDL cholesterol is associated with small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2003 26 618 622. doi: 10.1016/S1078
46. Harrison SC, Smith AJ, Jones GT, Aneurysm Consortium Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J 2013 34 3707 3716. doi: 10.1093/eurheartj/ehs354
47. Naydeck BL, Sutton-Tyrrell K, Schiller KD, Newman AB, Kuller LH., Prevalence and risk factors for abdominal aortic aneurysms in older adults with and without isolated systolic hypertension. Am J Cardiol 1999 83 759 764
48. Strehlow K, Wassmann S, Böhm M, Nickenig G., Angiotensin AT1 receptor over-expression in hypercholesterolaemia. Ann Med 2000 32 386 389
49. Cassis LA, Rateri DL, Lu H, Daugherty A., Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 2007 27 380 386. doi: 10.1161/01.ATV.0000254680.71485.92
50. Sparks MA, Parsons KK, Stegbauer J, Gurley SB, Vivekanandan-Giri A, Fortner CN, Snouwaert J, Raasch EW, Griffiths RC, Haystead TA, Le TH, Pennathur S, Koller B, Coffman TM., Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension. Hypertension 2011 57 577 585. doi: 10.1161/HYPERTENSIONAHA.110.165274
51. Rateri DL, Moorleghen JJ, Knight V, Balakrishnan A, Howatt DA, Cassis LA, Daugherty A., Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice. PLoS One 2012 7 e51483. doi: 10.1371/journal.pone.0051483
52. Saraff K, Babamusta F, Cassis LA, Daugherty A., Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003 23 1621 1626. doi: 10.1161/01.ATV.0000085631.76095.64
53. Rateri DL, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, Daugherty A., Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol 2011 179 1542 1548. doi: 10.1016/j.ajpath.2011.05.049
54. Tall AR, Yvan-Charvet L, Westerterp M, Murphy AJ., Cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis. Arterioscler Thromb Vasc Biol 2012 32 2547 2552. doi: 10.1161/ATVBAHA.112.300134
55. Mellak S, Ait-Oufella H, Esposito B, Loyer X, Poirier M, Tedder TF, Tedgui A, Mallat Z, Potteaux S., Angiotensin II mobilizes spleen monocytes to promote the development of abdominal aortic aneurysm in Apoe-/-mice. Arterioscler Thromb Vasc Biol 2015 35 378 388. doi: 10.1161/ATVBAHA.114.304389
56. Manning MW, Cassi LA, Huang J, Szilvassy SJ, Daugherty A., Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med 2002 7 45 54